Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06535503

Clinical Characteristics and Outcomes Among STEMI Patients With Cardiogenic Shock at Abu Dhabi City

A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

ST Elevation Myocardial Infarction Cardiogenic Shock Cardiovascular Diseases Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Shock Shock, Cardiogenic Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sheikh Khalifa Medical City (SKMC), Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates

Loading trial locations.

About this study

Cardiovascular disease (CVD) accounts for 40% of mortality in the UAE, which is higher than the global average. Long-term trends, incidence studies, and best practice guidance on Cardiogenic Shock (CS) with ST-elevation Myocardial infarction (STEMI) in the United Arab Emirates (UAE) and the Gulf Cooperation Council (GCC) are limited.

Through this retrospective study, investigators aim to identify treatment modalities and trends, hospitalization events, and patient demographics and comorbidities which lead to participant recovery or mortality in Sheikh Khalifa Medical City (SKMC) and Sheikh Shakhbout Medical City (SSMC) tertiary hospitals for patients admitted with STEMI and CS or developed CS after hospitalization with STEMI during January 2020-January 2024.[200-400 participants]. Data will be collected from eligible patients' electronic medical records (EMR).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age more than 18.
  • STEMI complicated by cardiogenic shock.
  • Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock.
  • Patient admitted between January 2019 to March 2024.

Exclusion criteria

  • Age less than 18.
  • Shock patient not related to Myocardial infarction.
  • NSTEMI-related cardiogenic shock.
  • Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock.
  • Patient not admitted between January 2019 to March 2024.

Treatment and study plan

Primary outcomes

  1. Analyze STEMI patient with CS disease profile

    Time frame: 5 years

    Comorbidities, demographical information, past medical history, morbidity

  2. Incidence of CS-complicated AMI events

    Time frame: 5 years

    The incidence of CS-complicated AMI events will show an increase over the years because of advanced diagnostic modalities and a clearer definition of CS.

  3. Analyze treatment outcomes in the targeted population as per the patient profile

    Time frame: 5 years

    Incidence of Mortality

  4. Analyze STEMI patient with CS disease profile

    Time frame: 5 years

    Incidence of Morbidity

  5. Analyze treatment outcomes

    Time frame: 5 years

    % of patients who were discharged

Study contacts

Contact information is provided by the study sponsor or research team.

Alina Naeem, MBBS

CONTACT

[email protected]

0097124102534

Babiker Babiker Mohamed Babiker Elsiraj MB Elsiraj, MD

CONTACT

[email protected]

0564972830

Sponsors and collaborators

Lead sponsor

Abu Dhabi Health Services Company

Other Gov

Collaborators

  • Sheikh Khalifa Medical City
  • Sheikh Shakhbout Medical City

Registry information

Official study title

Clinical Characteristics and Outcomes Among ST-elevation Myocardial Infarction (STEMI) Patients With Cardiogenic Shock at Abu Dhabi City

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 2, 2024
Registry last updated
Feb 17, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.